Related Experiment Video
Updated: Aug 13, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
[Current Status and Future Direction of Cancer Genomic Medicine in Japan]
1Dept. of Therapeutic Oncology, Graduate School of Medicine, Kyoto University.
Abstract:
From June, 2019, 2 different cancer genomic profiling(CGP)test panels(OncoguideNCCOncopanel, FoundationOneCDx) were decided to be covered by National Insurance System in Japan. To run the precision medicine based on CGP(genomic medicine), Ministry of Health, Labour and Welfare of Japan assigned the 11 certified core hospitals on genomic medicine, 34 sub-core hospitals and affiliated hospitals. In addition, Center for Cancer Genomics and Advanced Therapeutics(C-CAT) was established to collect genomic data and clinical data from these hospitals in June, 2018. To reimburse the genomic medicine, so called "expert-panel" with sufficient required specialists(eg medical oncologist, pathologist, genomic counselor, bioinformatician, et al)must be held to discuss on the treatment strategy and secondary findings. The expert panel was held by certified core hospital for genomic medicine and their affiliated hospital should join it. One of the important problems is the availability for drug based on genomic panel. In real world, only 10-15%of the patients can access the drug as a clinical trial. Secondary findings are also important issue to manage. To improve the operation and management of genomic medicine in clinical practice, we have to solve these issues as soon as possible.
More Related Videos
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...